Tus kws kho mob
Inpatient Admission Notification and Prior Authorization Request Form (PDF)
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1371 - 1380 ntawm 4303
Tus kws kho mob
QP46-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 28, 2022
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP47-22 Medical Drug Management Update – Alpha-1 Proteinase Inhibitors
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP48-22 MHCP Pharmacy Benefit Exclusion for Korsuva™ and Leqvio®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP49-22 Commercial Pharmacy Benefit Exclusion for Carvykti™, Korsuva™, and Leqvio®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP50-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2022
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP51-22 Blue Cross Preferred Genetic Laboratory Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP53-22 New Operational Trends Dashboard
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
upcoming-policies-effective-august-1-2022.pdf